Literature DB >> 18552253

Characteristics and causes of immune dysfunction related to uremia and dialysis.

Aline Borsato Hauser1, Andréa E M Stinghen, Sawako Kato, Sérgio Bucharles, Carlos Aita, Yukio Yuzawa, Roberto Pecoits-Filho.   

Abstract

From the immunologic viewpoint, chronic kidney disease (CKD) is characterized by disorders of both the innate and adaptive systems, generating a complex and still not fully understood immune dysfunction. Markers of a chronically activated immune system are closely linked to several complications of CKD and represent powerful predictors for mortality in the CKD population. On the other hand, CKD patients respond poorly to vaccination and to challenges such as bacterial infection. Interestingly, the main causes of death in patients with CKD are cardiovascular and infectious diseases, both being pathologic processes closely linked to immune function. Therefore, accelerated tissue degeneration (as a consequence of chronic inflammation) and increased rate of sepsis (because of a poorly orchestrated immune response) represent the most important targets for interventions aiming to reduce mortality in CKD patients. Understanding the mechanisms behind the immune dysfunction that is peculiar to CKD generates a perspective to improve outcomes in this group of patients.

Entities:  

Mesh:

Year:  2008        PMID: 18552253

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  59 in total

1.  Proton Pump Inhibitor-Associated C. difficile Infection in a Peritoneal Dialysis Patient.

Authors:  Susan L Ziolkowski; Michelle H Malabanan; Scott E Liebman
Journal:  Perit Dial Int       Date:  2015 Sep-Oct       Impact factor: 1.756

Review 2.  Uremic Toxicity of Advanced Glycation End Products in CKD.

Authors:  Andréa E M Stinghen; Ziad A Massy; Helen Vlassara; Gary E Striker; Agnès Boullier
Journal:  J Am Soc Nephrol       Date:  2015-08-26       Impact factor: 10.121

3.  Clinical and hematological data to group different chronic kidney disease patients: A practical approach to establish different groups of patients.

Authors:  Vinícius B Péterle; Jéssica de O Souza; Fernanda de O Busato; Frederico J Eutrópio; Gisele de A P da Costa; David N Olivieri; Carlos E Tadokoro
Journal:  J Clin Lab Anal       Date:  2018-01-04       Impact factor: 2.352

4.  Low Dietary Intake of Vitamin D and Vitamin D Deficiency in Hemodialysis Patients.

Authors:  Maria Krassilnikova; Katya Ostrow; Amanda Bader; Peter Heeger; Anita Mehrotra
Journal:  J Nephrol Ther       Date:  2014-05-15

5.  Novel multivariate methods for integration of genomics and proteomics data: applications in a kidney transplant rejection study.

Authors:  Oliver P Günther; Heesun Shin; Raymond T Ng; W Robert McMaster; Bruce M McManus; Paul A Keown; Scott J Tebbutt; Kim-Anh Lê Cao
Journal:  OMICS       Date:  2014-11

6.  Vaccinating the Patient with ESKD.

Authors:  Sana F Khan; Brendan T Bowman
Journal:  Clin J Am Soc Nephrol       Date:  2019-07-01       Impact factor: 8.237

7.  Obtaining regulatory T cells from uraemic patients awaiting kidney transplantation for use in clinical trials.

Authors:  D Berglund; M Karlsson; A-R Biglarnia; T Lorant; G Tufveson; O Korsgren; B Carlsson
Journal:  Clin Exp Immunol       Date:  2013-08       Impact factor: 4.330

8.  Effect of Different Dialysis Methods on Cellular Immunity Function of Maintenance Haemodialysis Patients.

Authors:  L Xing
Journal:  West Indian Med J       Date:  2016-04-29       Impact factor: 0.171

9.  Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccine Among Patients Receiving Maintenance Hemodialysis.

Authors:  Anne M Butler; J Bradley Layton; Vikas R Dharnidharka; John M Sahrmann; Marissa J Seamans; David J Weber; Leah J McGrath
Journal:  Am J Kidney Dis       Date:  2019-08-01       Impact factor: 8.860

Review 10.  Chronic dialysis in patients with end-stage renal disease: Relevance to kidney xenotransplantation.

Authors:  Abhijit Jagdale; David K C Cooper; Hayato Iwase; Robert S Gaston
Journal:  Xenotransplantation       Date:  2018-11-20       Impact factor: 3.907

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.